Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment

Zhou, Linlin; Yu, Chen-Wei

doi:10.1016/j.phrs.2024.107205

Pharmacological Research

2024

DOI: 10.1016/j.phrs.2024.107205

|View full text |Cite

Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment

Linlin Zhou,

Chen-Wei Yu

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

References 167 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective

Djamgoz

2024

Stem Cell Rev and Rep

View full text Add to dashboard Cite

Stemness, giving cancer cells massive plasticity enabling them to survive in dynamic (e.g. hypoxic) environments and become resistant to treatment, especially chemotherapy, is an important property of aggressive tumours. Here, we review some essentials of cancer stemness focusing on triple-negative breast cancer (TNBC), the most aggressive form of all breast cancers. TNBC cells express a range of genes and mechanisms associated with stemness, including the fundamental four “Yamanaka factors”. Most of the evidence concerns the transcription factor / oncogene c-Myc and an interesting case is the expression of the neonatal splice variant of voltage-gated sodium channel subtype Nav1.5. On the whole, measures that reduce the stemness make cancer cells less aggressive, reducing their invasive/metastatic potential and increasing/restoring their chemosensitivity. Such measures include gene silencing techniques, epigenetic therapies as well as novel approaches like optogenetics aiming to modulate the plasma membrane voltage. Indeed, simply hyperpolarizing their membrane potential can make stem cells differentiate. Finally, we give an overview of the clinical aspects and exploitation of cancer/TNBC stemness, including diagnostics and therapeutics. In particular, personalised mRNA-based therapies and mechanistically meaningful combinations are promising and the emerging discipline of ‘cancer neuroscience’ is providing novel insights to both fundamental issues and clinical applications. Graphical Abstract

show abstract

Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective

Djamgoz

2024

Stem Cell Rev and Rep

View full text Add to dashboard Cite

show abstract

Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors

Wu,

Chen,

Wang

et al. 2024

Chemical Engineering Journal

View full text Add to dashboard Cite

Advancements in Clinical Research and Emerging Therapies for Triple-Negative Breast Cancer Treatment

Xu,

Wang

et al. 2024

European Journal of Pharmacology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment

Cited by 5 publications

References 167 publications

Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective

Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective

Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors

Advancements in Clinical Research and Emerging Therapies for Triple-Negative Breast Cancer Treatment

Contact Info

Product

Resources

About